Effectiveness of Riboflavin-Moxifloxacin Amniotic Membrane as an Adjuvant for PACK-CXL in Moderate to Severe Infectious Keratitis
Clinical trial NCT07559149 · COMPLETED
Trial details
- NCT number
- NCT07559149
- Sponsor
- Gadjah Mada University
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-07-07
- Primary completion
- 2025-02-13
- Enrollment
- 32
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.